Radium-223 dichloride (Xofigo, BAY 88-8223)

Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases